Clearview Wealth Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Clearview Wealth Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$775.18 - $881.7 $10,077 - $11,462	13 Added 1.54%	855 $750,000
Q3 2023 Oct 30, 2023	BUY	$692.45 - $844.37 $583,042 - $710,959	842 New	842 $692,000
Q2 2021 Jul 30, 2021	SELL	$472.8 - $558.54 $17,020 - $20,107	-36 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$478.3 - $607.98 $17,218 - $21,887	36 New	36 $17,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Clearview Wealth Advisors LLC with notifications on news.